Overactive Bladder: Identifying Patients at Risk, Implementing New Strategies
|
|
- Randell Andrews
- 6 years ago
- Views:
Transcription
1 Overactive Bladder: Identifying Patients at Risk, Implementing New Learning Objectives Identify patients with OAB risk factors in order to proactively initiate a discussion about bladder symptoms and establish a diagnosis Educate patients on the management of OAB, including pharmacologic and nonpharmacologic strategies and the importance of adherence and follow-up Individualize the pharmacologic treatment of OAB based on the efficacy, dosing, metabolism, and side-effect profiles of available agents 2 OAB = overactive bladder. Virginia, 74, is unhappy with her antimuscarinic therapy for OAB She has taken immediate- and extended-release antimuscarinics but is not satisfied with the results Although she has had some improvement in symptoms, she continues to experience urgency 7-8 times per day She also complains of dry mouth and constipation She takes medications for diabetes, hypertension, and depression 3 1
2 Definitions of Incontinence From the International Continence Society UI Complaint of involuntary leakage of urine UUI Complaint of involuntary leakage associated with urgency SUI Complaint of involuntary leakage upon exertion, effort, sneezing, or coughing Mixed UI Complaint of involuntary leakage associated with urgency and upon exertion, effort, sneezing, or coughing SUI = stress urinary incontinence; UI = urinary incontinence; UUI = urgency urinary incontinence. 4 Abrams P, et al. Neurourol Urodyn. 2002;21: ; Haylen BT, et al. Neurourol Urodyn. 2010;29:4-20. Definitions of Incontinence From the International Continence Society (cont d) Nocturia Complaint that the individual has to wake at night 1 times to void Urgency Complaint of sudden, compelling urge to pass urine that is difficult to defer Increased daytime frequency Complaint that voiding occurs more frequently during waking hours than deemed normal by patient OAB Urinary urgency, usually accompanied by frequency and nocturia, with or without UUI a a In the absence of urinary tract infection (UTI) or other obvious pathology. 5 Abrams P, et al. Neurourol Urodyn. 2002;21: ; Haylen BT, et al. Neurourol Urodyn. 2010;29:4-20. Storage Problem: Incontinence Normal (No Incontinence) Large capacity, relaxed bladder High-resistance urethra Urethra Bladder Urgency/UUI Small capacity, OAB Urine loss, accompanied by urgency Bladder Urethra SUI Low-resistance urethra Urine loss resulting from sudden increased Urethra intra-abdominal pressure (eg, laugh, cough, sneeze) Bladder Mixed Small capacity, hyperactive bladder Urethra Low-resistance urethra Combination of SUI and UUI Bladder OAB 6 Abrams P, et al. The Overactive Bladder: A Widespread and Treatable Condition. 1998; Clare J, et al. Nat Rev Neurosci. 2008;9: ; Gormley EA, et al. J Urol. 2015;193: ; Wein AJ, et al. Urology. 2002;60(5 Suppl 1):
3 OAB Is Very Common in Both Men and Women 1 in 3 US adults aged 40 years reported symptoms of OAB at least sometimes Respondents (%) Men Women Age (Years) 7 Coyne S, et al. Urology. 2011;77: Key Populations: Patients With Diabetes and Obesity Survey of 1359 patients with T2DM: 22.5% had OAB, of whom 48% had UI 1 - Higher A1C levels predict increased risk for OAB/urgency, UUI, and nocturia in patients with T2DM 2 - Women who are overweight or obese and have T2DM: higher prevalence of UI than with other T2DM complications 1,3 - Women with obesity twice as likely to have OAB than women of normal weight 4 A1C = glycated hemoglobin Liu RT, et al. Urology. 2011;78: ; 2. Chiu A-F, et al. Int J Urol. 2012;19: ; 3. Phelan S, et al. Diabetes Care. 2009;32: ; 4. Cheung WW, et al. Open Access J Urol. 2011;3: The Iceberg of Care for Women Aged 40 Years With UI: Underreported and Undertreated Women with UI who seek care tend to be older, have more severe symptoms of longer duration, and have bothersome symptoms that impact QoL Primary care interventions are key to preventing worsening of UI, especially because so few patients ever see pelvic floor specialists Proportion of women with UI receiving subspecialty care: 12% (164/1366) Proportion of women with UI receiving care: 23% (313/1366) Proportion of women with UI seeking care: 25% (339/1366) Prevalence of UI in women aged 40 years based on responses to a bladder health survey: 41% (1366/3316) QoL = quality of life. 9 Minassian VA, et al. Int Urogynecol J. 2012;23:
4 Provider and Patient Perceptions Differ In 85% of cases, female patients have to initiate the discussion about their incontinence symptoms with their clinician Only one-third of patients with a diagnosis of OAB receive treatment 56% of women with OAB wait >1 year to seek treatment (mean 3.1 years) Providers may not recognize the association of OAB and depression, particularly with more severe OAB 10 Dmochowski RR, et al. Curr Med Res Opin. 2007;23:65-76; Dmochowski RR. Int Urogynecol J Pelvic Floor Dysfunct. 2006;17: ; Lai HH, et al. BMC Neurol. 2016;16:60 Why Patients Do or Do Not Seek Help Why not seek help? Embarrassed Not asked by clinician Do not think it is serious Coping mechanisms Misconception about disease/ normal aging process Why seek help? Getting worse Fear of more serious condition Concern of embarrassing accident 11 Dmochowski RR. Int Urogynecol J Pelvic Floor Dysfunct. 2006;15: ; Dmochowski RR, et al. Curr Med Res Opin. 2007;23:65-76; Irwin SDE, et al. BJU Int. 2006;97:96-100; Muller N. Urol Nurs. 2005;25: ; Ricci JA, et al. Clin Ther. 2001;23: ; Sandman D, Trauring A. Survey of Adult Women With Overactive Bladder. 2003; Tyagi S, et al. Urol Clin North Am. 2006;33: Case Study: Mrs Jones Presents for a Follow-up Appointment Mrs Jones, age 73 years, presents for follow-up of T2DM Works part-time as a bookkeeper Medical history: Severe OA, for which she regularly takes ibuprofen T2DM, poorly controlled with metformin Depression, for which she has taken venlafaxine Broke her hip 6 months ago Has recovered well, but worries about falling again Has a part-time job as a bookkeeper What avenues should you be exploring with Mrs Jones? 12 OA = osteoarthritis. 4
5 Let s Meet Mrs Jones 13 Useful Questions to Direct the Diagnosis of OAB In a survey, most patients said they would prefer their clinician to initiate the conversation on OAB, yet only 14% said their clinician asked them about urinary/bladder symptoms Urgency Frequency Nocturia UUI Do you frequently have strong urges to urinate? Do you urinate more often than you think you should? Do you go to the bathroom so often that it interferes with your activities? Are you bothered by waking up at night to go to the bathroom? Do you have uncontrollable urges to urinate that sometimes result in wetting accidents? Do you leak urine on the way to the bathroom? 14 Dmochowski RR, et al. Curr Med Res Opin. 2007;23:65-76; Filipetto FA, et al. BMC Fam Pract. 2014;15:96; Newman DK. Nurse Pract. 2009;34:33-45; Newman DK, et al. Am J Nurs. 2002;102:36-45; Rosenberg MT, et al. Can J Urol. 2014;21(Suppl 2):7-16; Sussman DO. J Am Osteopath Assoc. 2007;107: Typical Bladder Diary Time Voided Activity Leakage Urge Present Fluid Intake (Amount/Type) 4:00 AM In bed/rushed to bathroom Yes Yes 6:30 Morning routine Yes Yes 20 oz coffee 8:40 Waited too long Yes Strong 8 oz water 10:00 Yes 10:15 Yes 6 oz juice 12:35 PM Housework Yes Strong 12 oz cola 2:30 Yes 8 oz water 4:20 Yes 6 oz tea 6:20 Dinner Yes Strong 8 oz beer 7:35 Yes No 8 oz water 10:10 Yes 4 oz water 1:20 AM Yes 15 Frequency = 12; fluid intake = 80 oz. 5
6 Differential Diagnosis: OAB, SUI, and UTI Symptom OAB SUI UTI Urgency Yes No Yes Daytime voiding frequency every >2 hours Yes No Yes Leaking during physical activity No Yes No Amount of urinary leakage Variable Variable Small Ability to reach the toilet following an urge Often no Yes Sometimes no Nocturia Usually Not often Rarely 16 Abrams P, et al. The Overactive Bladder: A Widespread and Treatable Condition Mrs Jones Returns a Month Later Mrs Jones returns with her bladder diary, which is incomplete, but suggests nocturia ~2 times/night and frequent daytime urgency She has a negative urinalysis result Based on her bladder diary, history of T2DM, normal physical exam, and a negative urinalysis, you believe she has OAB Mrs Jones needs education and lifestyle strategies 17 Pelvic Floor Rehabilitation: Pelvic Floor (Kegel) Muscle Exercises Exercises increase muscle tone/strength Help hold urine inside bladder, preventing leakage; decrease median number of voids per day Urge suppression; rapid, active pelvic muscle contractions ( quick flicks ) inhibit unstable bladder contraction once it starts Superior efficacy versus oxybutynin and placebo, with less desire to change therapy Recommended by ACP as first-line treatment for women with SUI and in combination with bladder training in women with mixed UI Repeat in sets of up to 10 3 times/day Locate pelvic muscles Relax completely for at least 10 seconds Yes! There is an App! Squeeze muscles tightly for up to 10 seconds 18 ACP = American College of Physicians. Burgio KL, et al. JAMA. 1998;280: ; Newman DK. Accessed Aug 29, 2017; Qaseem A, et al. Ann Intern Med. 2014;161: ; Urology Care Foundation. Accessed Sep 19,
7 Behavioral Therapy: Multiple Options Less than one-third of patients with OAB or other urinary symptoms are offered behavioral management options Scheduled toileting programs Pelvic floor muscle exercises with biofeedback therapy Education Behavioral interventions Lifestyle interventions Bladder training; urge-suppression strategies 19 Filipetto FA, et al. BMC Fam Pract. 2014;15:96; Gormley EA, et al. J Urol. 2015;193: ; Jayarajan J, et al. Res Rep Urol. 2013;6:1-16. Lifestyle Changes Weight loss Smoking cessation Managing constipation Fluid intake (adequate) Caffeine consumption Physical exercise Awareness of toileting behaviors 20 Moore K, et al. In: Abrams P, et al, eds. Incontinence: Proceedings From the 5th International Consultation on Incontinence. 2013: Behavior Change: Reducing Fluid Intake Reducing fluid intake by 25% significantly improves urgency, frequency, nocturia Water Intake Calculator 21 Hashim H, et al. BJU Int. 2008;102:62-66; Water Intake Calculator. Accessed Oct 12,
8 Mrs Jones Returns 2 Months Later Mrs Jones reports that she is diligently following the lifestyle modifications that you discussed with her She restricts fluid (especially at night) and has given up caffeine and her usual glass of wine in the evening Does kegels regularly Uses suppression strategies to minimize urgency Her bladder diary shows fewer episodes of urgency, but she is still concerned about rushing to the bathroom, the potential for injury, and leaking She is very concerned that people at work are noticing her frequent trips and that it could jeopardize her job 22 Talking to Mrs Jones About Medications 23 AUA Treatment Recommendations Line of Therapy First Second Third a Fourth b Treatment [Evidence Strength Grade] Behavioral therapies [B] Behavioral and pharmacologic therapies [C] Pharmacologic therapy a (antimuscarinics, β 3 -agonists) [B] OnabotulinumtoxinA [B] Peripheral tibial nerve stimulation [C] Sacral neuromodulation [C] Augmentation cystoplasty [Expert Opinion] Urinary diversion [Expert Opinion] a Patients who do not respond to or cannot tolerate first- or second-line therapies should be referred to a specialist for additional therapy; b Severe, refractory, complicated cases. AUA = American Urological Association. 24 Gormley EA, et al. J Urol. 2015;193:
9 Antimuscarinic Treatment Options Drug Dose, mg Frequency 25 Oxybutynin ER 5-15 Once daily Oxybutynin IR times daily Oxybutynin gel 10% 1 g Once daily Oxybutynin transdermal patch a 3.9 Twice weekly Tolterodine 1-2 Twice daily Tolterodine long-acting 2-4 Once daily Darifenacin Once daily Fesoterodine 4-8 Once daily Solifenacin 5-10 Once daily Trospium 20 Twice daily Trospium ER 60 Once daily a Approved for over-the-counter use in women. ER = extended release; IR = immediate release. Prescribers Digital Reference. Accessed Oct 25, Common Side Effects of Antimuscarinics Dry mouth Constipation Headaches Blurred vision Clinicians should manage constipation and dry mouth before abandoning effective antimuscarinic therapy Patient must decide if the efficacy of the medication is worth side effects Some patients Balance tolerate of severe efficacy side and effects tolerability better should than others be considered and discussed with each patient 26 Steers WD. Urol Clin North Am. 2006;33: Erdam N, et al. Am J. Med 2006;119(suppl 1): Gormley EA, et al. American Urological Association (AUA) Guideline. AUA Web site Accessed Oct 25, Contraindications, Warnings, and Precautions for Antimuscarinics Contraindications Urinary or gastric retention Uncontrolled narrow-angle glaucoma Warnings and precautions Clinically significant bladder outlet obstruction Decreased gastrointestinal motility Treated narrow angle glaucoma May have central nervous system effects (eg, somnolence) Use with caution in patients with myasthenia gravis 27 Physicians Desk Reference. 64th ed. Thomson PDR; 2010; Oelke M, et al. Eur Urol. 2013;64:
10 Antimuscarinics: Comments and Concerns All have comparable efficacy Adherence/persistence rates low ER medications preferred over IR formulations: lower rates of dry mouth Use caution in patients taking other medications with anticholinergic properties Antidepressants, medications for Parkinson s disease and Alzheimer s disease, antinausea medications, etc Use caution when prescribing to frail and elderly patients Mobility deficits Cognitive deficits 28 Gormley EA, et al. J Urol. 2015;193: ; Jayarajan J, Radomski SB. Res Rep Urol. 2013;6:1-16. Mirabegron: A Different Mechanism of Action Bladder Activates β 3 -adrenergic receptors on the detrusor smooth muscle Relaxes the muscle during the storage phase of the urinary bladder fill void cycle and increases bladder capacity Pelvic nerve ACh (parasympathetic) NE Hypogastric nerve (sympathetic) M3 receptor (+) β 3 receptor (-) NE Detrusor muscle Urethra α1 receptor (+) Therapeutic Class Dose, mg Frequency β 3-adrenergic agonist 25 and 50 Once daily ACh = acetylcholine; NE = norepinephrine. 29 Bhide AA, et al. Int Urogynecol J. 2012;23: ; Clare J, et al. Nat Rev Neurosci. 2008;9: ; Tyagi P, et al. Drugs. 2010;13: Mirabegron: Incontinence Episodes Per 24 Hours Co-primary end point: mean number of incontinence episodes/24 hours adjusted mean change from baseline to final visit (week 12) a Study 1 Study 2 Study 3 Mean Number of Incontinence Episodes/24 Hours Baseline n = 291 n = 293 n = 325 n = 312 n = 262 n = 254 n = b 1.36b 1.47 b 1.57 b Placebo Mirabegron 25 mg Mirabegron 50 mg a Adjusted mean is for baseline, sex, and geographic location; b P.05 vs placebo with multiplicity adjustments. 30 Herschorn S, et al. Urology. 2013;82: ; Khullar V, et al. Eur Urol. 2013;63: ; Myrbetriq [prescribing information]. Astellas; 2017; Nitti VW, et al. J Urol. 2013;189:
11 Mirabegron: Common Side Effects Hypertension Nasopharyngitis UTIs Headaches Balance of efficacy and tolerability should be considered and discussed with each patient 31 Myrbetriq [prescribing information]. Astellas; Contraindications, Warnings, and Precautions for Mirabegron No contraindications Warnings and precautions: Not recommended for patients with severe uncontrolled hypertension Use with caution in patients: With urinary retention with bladder outlet obstruction Taking antimuscarinic for OAB Taking drugs metabolized by CYP2D6 (mirabegron is moderate inhibitor) 32 Myrbetriq [prescribing information]. Astellas; BESIDE: Combination Therapy When Monotherapy Fails Mean (SE) Adjusted Change From BL to EoT: Incontinence Episodes Baseline (SE) 3.24 (0.11) 3.15 (0.10) 3.31 (0.12) Combination Solifenacin 5 mg Solifenacin 10 mg (n = 706) 1.80 Incontinence Episodes (n = 704) 1.53 Difference vs solifenacin 5 mg 0.26 (95% CI, 0.47 to 0.05) P =.001* (n = 697) 1.67 Difference vs solifenacin 10 mg 0.13 (95% CI, 0.34 to 0.08) P =.008 Combination = solifenacin 5 mg + mirabegron 25 mg (50 mg after 4 weeks) *P <.05 vs solifenacin 5 mg; P <.05 vs solifenacin 10 mg. BL = baseline; CI = confidence interval; EoT = end of treatment; SE = standard error. 33 Drake MJ, et al. Eur J Urol. 2016;70:
12 BESIDE: Combination of Antimuscarinic + β 3 Agonist Therapy Better Tolerated OAB-q Symptom Bother Health-Related QoL Improvement Baseline (SE) Mean (SE) Adjusted Change From Baseline to EoT Combination Solifenacin 5 mg Solifenacin 10 mg (0.76) (0.78) (0.78) (n = 694) (n = 683) (n = 676) Difference vs Difference vs solifenacin 5 mg solifenacin 10 mg (95% CI, 6.88 to 3.04) (95% CI, 5.23 to 1.37) P <.001 P =0.001 Improvement Mean (SE) Adjusted Change From Baseline to EoT Difference vs Difference vs solifenacin 5 mg solifenacin 10 mg (95% CI, ) (95% CI, ) P <.001 P < (n = 694) (n = 683) (n = 676) 0 Baseline (SE) (0.85) (0.89) (0.87) Combination Solifenacin 5 mg Solifenacin 10 mg 34 Drake MJ, et al. Eur J Urol. 2016;70: Safety Results of Combination Therapy a Combination Solifenacin 5 mg Solifenacin 10 mg Treatment-Emergent AE, n (%) (n = 725) (n = 728) (n = 719) Increased BP 12 (1.7) 6 (0.8) 13 (1.8) QT prolongation 1 (0.1) 1 (0.1) 2 (0.3) Increased heart rate, palpitations, 7 (1.0) 5 (0.7) 4 (0.6) tachycardia, atrial fibrillation Tachycardia 2 (0.3) 3 (0.4) 1 (0.1) UTI 17 (2.3) 16 (2.2) 20 (2.8) Urinary retention 2 (0.3) 1 (0.1) 5 (0.7) Acute urinary retention Hypersensitivity reactions 11 (1.5) 6 (0.8) 6 (0.8) Glaucoma Dry mouth 43 (5.9) 41 (5.6) 70 (9.7) Blurred vision 10 (1.4) 10 (1.4) 5 (0.7) Constipation 33 (4.6) 22 (3.0) 34 (4.7) a Treatment-emergent adverse events (AEs) of special interest. 35 Drake MJ, et al. Eur J Urol. 2016;70: Indications for Referral Refractory to behavioral and pharmacologic therapy Neurologic disease or suspicion of neurologic cause of symptoms History of genitourinary trauma Pelvic pain Uncertain diagnosis or patient choice History of recurrent UTIs, other infection Pelvic irradiation Hematuria (microscopic or gross) Prior genitourinary surgery Elevated prostate-specific antigen Abnormal genital exam 36 Rosenberg MT, et al. Int J Clin Pract. 2007;61:
13 Therapy for Refractory OAB OnabotulinumtoxinA: injection 12 weeks; 24 weeks typical Reduces number of incontinence episodes and urgency, improves QoL AEs: UTI (34%-48%); urinary retention (6%) Peripheral tibial nerve stimulation: weekly 30-minute in-office sessions Efficacy in refractory OAB AEs: mild and uncommon Sacral neuromodulation: implanted device Improves OAB symptoms and continence vs standard medical therapy AEs: related to implanted device 37 Botox [prescribing information]. Allergan; 2013; Gormley EA, et al. J Urol. 2015;193: ; Gormley EA, et al. education/clinical-guidance/overactive-bladder.pdf. Accessed Sep 11, 2017; Siegel S, et al. Neurourol Urodyn. 2015;34: Action Plan Initiate discussion about bladder control with patients Use a bladder diary to assist in the diagnosis and monitoring of symptom improvement Institute nonpharmacologic strategies to improve OAB symptoms as a foundation of every treatment program Tailor medication to each patient s comorbidities, response, and tolerability Consider combination therapy with agents from different classes if monotherapy provides insufficient relief PCE Promotes Practice Change 38 13
TREATMENT OF OVERACTIVE BLADDER IN ADULTS FUGA 2016 KGH
TREATMENT OF OVERACTIVE BLADDER IN ADULTS FUGA 2016 KGH CONTENTS Overactive bladder (OAB) Treatment of OAB Beta-3 adrenoceptor agonist (Betmiga ) - Panacea? LASER treatment - a flash in the pan or the
More informationManagement of OAB. Lynsey McHugh. Consultant Urological Surgeon. Lancashire Teaching Hospitals
Management of OAB Lynsey McHugh Consultant Urological Surgeon Lancashire Teaching Hospitals Summary Physiology Epidemiology Definitions NICE guidelines Evaluation Conservative management Medical management
More informationOveractive Bladder Syndrome
Overactive Bladder Syndrome behavioural modifications to pharmacological and surgical treatments Dr Jos Jayarajan Urologist Austin Health, Eastern Health Warringal Private, Northpark Private, Epworth Overactive
More informationDiagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline.
Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline. TARGET POPULATION Eligibility Decidable (Y or N) Inclusion Criterion non-neurogenic OAB Exclusion Criterion
More informationUrogynecology Office. Can You Hold? An Update on the Treatment of OAB. Can You Hold? Urogynecology Office
Urogynecology Office Urogynecology Office Can You Hold? An Update on the Treatment of OAB Can You Hold? Karen Noblett, MD Professor and Chair Department of OB/GYN University of California, Riverside Disclosures
More informationObjectives. Prevalence of Urinary Incontinence URINARY INCONTINENCE: EVALUATION AND CURRENT TREATMENT OPTIONS
URINARY INCONTINENCE: EVALUATION AND CURRENT TREATMENT OPTIONS Lisa S Pair, MSN, CRNP Division of Urogynecology and Pelvic Reconstructive Surgery Department of Obstetrics and Gynecology University of Alabama
More informationOAB Treatment Guidelines
OAB Treatment Guidelines This Practice Aid has been provided as a quick reference to help learners apply the information to their daily practice and care of patients. It is part of the activity Overcoming
More informationVarious Types. Ralph Boling, DO, FACOG
Various Types Ralph Boling, DO, FACOG The goal of this lecture is to increase assessment and treatment abilities for physicians managing urinary incontinence (UI) patients. 1. Effectively communicate with
More informationPrimary Care management of Overactive Bladder (OAB)
DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) Primary Care management of Overactive Bladder (OAB) Prescribing Tips All medicines for OAB have similar dose-related efficacy. More than one agent (up
More informationUrinary Incontinence for the Primary Care Provider
Urinary Incontinence for the Primary Care Provider Diana J Scott FNP-BC https://youtu.be/gmzaue1ojn4 1 Assessment of Urinary Incontinence Urge Stress Mixed Other overflow, postural, continuous, insensible,
More informationCoping with urges and leaks?
OAB AND YOU Coping with urges and leaks? Let me help you learn more about overactive bladder (OAB) symptoms and ways to help manage them 1 HOW DOES THE BLADDER WORK? Within the urinary tract, the kidneys
More informationDiagnosis and Treatment of Urinary Incontinence. Urinary Incontinence
Diagnosis and Treatment of Urinary Incontinence Leslee L. Subak, MD Professor Obstetrics, Gynecology & RS Epidemiology, Urology University of California, San Francisco Urinary Incontinence Common - 25%
More informationOveractive bladder can result from one or more of the following causes:
Overactive bladder can affect people of any age; however, it is more common in older people. Effective treatments are available and seeing your doctor for symptoms of overactive bladder often results in
More informationURGE MOTOR INCONTINENCE
URGE MOTOR INCONTINENCE URGE INCONTINENCE COMMONEST TYPE IN ELDERLY WOMEN Causes: 1 - Defects in CNS regulation Stroke Parkinson s disease Dementia (Alzheimer s and other types) Normopressure hydrocephalus
More informationOveractive bladder (OAB) affects approximately 15% of the adult population. Diagnosis is based
Overactive bladder (OAB) affects approximately 15% of the adult population. Diagnosis is based upon a medical history, and includes a focused physical exam (abdominal, neurological, pelvic in females and
More informationOveractive Bladder beyond antimuscarinics
Overactive Bladder beyond antimuscarinics Marcus Drake Bristol Urological Institute Conflicts of interest; Allergan, AMS, Astellas, Ferring, Pfizer Getting the diagnosis right Improving treatment Improving
More informationBladder dysfunction in ALD and AMN
Bladder dysfunction in ALD and AMN Sara Simeoni, MD Department of Uro-Neurology National Hospital for Neurology and Neurosurgery Queen Square, London 10:15 Dr Sara Simeoni- Bladder issues for AMN patients
More informationOveractive bladder. Information for patients from Urogynaecology
Overactive bladder Information for patients from Urogynaecology An overactive bladder (OAB) is a very common problem. It can cause distressing symptoms that are difficult to control. These can include
More informationUrinary Incontinence. Vibhash Mishra Consultant Urological Surgeon Royal Free Hospital
Urinary Incontinence Vibhash Mishra Consultant Urological Surgeon Royal Free Hospital Affects women of all ages Impacts physical, psychological & social wellbeing Impact on families & carers Costs the
More informationTHE OVER-ACTIVE BLADDER (OAB)
THE OVER-ACTIVE BLADDER (OAB) Passage of urine is caused by the bladder muscle contracting coordinated with the relaxation of the sphincter muscles, which is controlled by higher centers in the central
More informationEvaluation & Management of Overactive Bladder
Evaluation & Management of Overactive Bladder Disclosures/Conflict of Interest/Bias I have no financial relationship with any of the companies that produce the products I m about to discuss I have no conflicts
More informationManagement of Female Stress Incontinence
Management of Female Stress Incontinence Dr. Arvind Goyal Associate Professor (Urology& Renal Transplant) Dayanand Medical College & Hospital, Ludhiana, Punjab, India Stress Incontinence Involuntary loss
More informationOveractive bladder syndrome (OAB)
Service: Urology Overactive bladder syndrome (OAB) Exceptional healthcare, personally delivered What is OAB? An overactive bladder or OAB is where a person regularly gets a sudden and compelling need or
More informationUrinary Incontinence in Women: Never an Acceptable Consequence of Aging
Urinary Incontinence in Women: Never an Acceptable Consequence of Aging Catherine A. Matthews, MD Associate Professor Chief, Urogynecology and Pelvic Reconstructive Surgery University of North Carolina,
More information3/20/10. Prevalence of OAB Men: 16.0% Women: 16.9% Prevalence of OAB with incontinence (OAB wet) Men: 2.6% Women: 9.3% Dry. Population (millions) Wet
1 Prevalence of OAB Men: 16.0% Women: 16.9% Stewart WF, et al. World J Urol. 2003;20:327-336. Prevalence of OAB with incontinence (OAB wet) Men: 2.6% Women: 9.3% Stewart WF, et al. World J Urol. 2003;20:327-336.
More informationAnticholinergic medication use for female overactive bladder in the ambulatory setting in the United States.
Página 1 de 6 PubMed darifenacin vs solifenacin Display Settings:, Sorted by Recently Added Results: 5 1. Int Urogynecol J. 2013 Oct 25. [Epub ahead of print] Anticholinergic medication use for female
More informationUsing Physiotherapy to Manage Urinary Incontinence in Women
Using Physiotherapy to Manage Urinary Incontinence in Women Bladder control problems are common, and affect people of all ages, genders and backgrounds. These problems are referred to as urinary incontinence
More informationManagement, Evaluation, and Treatment of Overactive Bladder and Urinary Incontinence
Management, Evaluation, and Treatment of Overactive Bladder and Urinary Incontinence Arthur Mourtzinos, MD, MBA Co-Vice Chair, Institute of Urology Director, Continence Center Assistant Professor of Urology,
More informationPresentation Goals 4/14/2015. Pharmacology for Urinary Incontinence in Women. Medications Review anti muscarinic medications Focus on newer meds
Presentation Goals Pharmacology for Urinary Incontinence in Women Medications Review anti muscarinic medications Focus on newer meds Introduce beta adrenergic medications Current Concepts in Drug Therapy
More informationY0028_2726_0 File&Use Bladder Control Does Matter
Y0028_2726_0 File&Use 04092012 Bladder Control Does Matter If you suffer from urinary incontinence, you re not alone Don t be afraid to raise your hand if you ve been struggling with the embarrassment
More informationKathleen C. Kobashi, MD, FACS Head, Section of Urology and Renal Transplantation Virginia Mason Medical Center, Seattle, WA
Kathleen C. Kobashi, MD, FACS Head, Section of Urology and Renal Transplantation Virginia Mason Medical Center, Seattle, WA Disclosures Advisory Board and/or Speaker Allergan Medtronic Astellas AUA Guidelines
More informationDiane K. Newman DNP, ANP-BC, PCB-PMD, FAAN
Diane K. Newman DNP, ANP-BC, PCB-PMD, FAAN Diane K. Newman, DNP is a Biofeedback Certified Continence Specialist. With over 35-years experience, she is an expert in the assessment and management of pelvic-floor
More informationURINARY INCONTINENCE. Urology Division, Surgery Department Medical Faculty, University of Sumatera Utara
URINARY INCONTINENCE Urology Division, Surgery Department Medical Faculty, University of Sumatera Utara Definition The involuntary loss of urine May denote a symptom, a sign or a condition Symptom the
More informationThe Evidence for Antimuscarinic Agents in Female Mixed Urinary Incontinence
european urology supplements 5 (2006) 849 853 available at www.sciencedirect.com journal homepage: www.europeanurology.com The Evidence for Antimuscarinic Agents in Female Mixed Urinary Incontinence Stefano
More informationNICE Pathways bring together all NICE guidance, quality standards and other NICE information on a specific topic.
bring together all NICE guidance, quality standards and other NICE information on a specific topic. are interactive and designed to be used online. They are updated regularly as new NICE guidance is published.
More informationMr. GIT KAH ANN. Pakar Klinikal Urologi Hospital Kuala Lumpur.
Mr. GIT KAH ANN Pakar Klinikal Urologi Hospital Kuala Lumpur drgitka@yahoo.com 25 Jan 2007 HIGHLIGHTS Introduction ICS Definition Making a Diagnosis Voiding Chart Investigation Urodynamics Ancillary Investigations
More informationOveractive Bladder: Diagnosis and Approaches to Treatment
Overactive Bladder: Diagnosis and Approaches to Treatment A Hidden Condition* Many Many patients self-manage by voiding frequently, reducing fluid intake, and wearing pads Nearly Nearly two-thirds thirds
More informationAdvanced Care for Female Overactive Bladder & Urinary Incontinence. Department of Urology Kaiser Permanente Santa Rosa
Advanced Care for Female Overactive Bladder & Urinary Incontinence Department of Urology Kaiser Permanente Santa Rosa Goals Participants will: Review normal urinary tract anatomy and function Understand
More informationOveractive Bladder. Jennifer Mosher, WHNP-BC, CUNP Mercy Health Pelvic Medicine and Urogynecology Muskegon, Michigan
Overactive Bladder Jennifer Mosher, WHNP-BC, CUNP Mercy Health Pelvic Medicine and Urogynecology Muskegon, Michigan Speaker Disclosure I have nothing to disclose. 2 Learning Objectives Define OAB Identify
More informationOveractive Bladder in Clinical Practice
Overactive Bladder in Clinical Practice Alan J. Wein Christopher Chapple Overactive Bladder in Clinical Practice Authors Alan J. Wein Division of Urology University of Pennsylvania Health System Philadelphia
More informationIncontinence: Risks, Causes and Care
Welcome To Incontinence: Risks, Causes and Care Presented by Kamal Masaki, MD Professor and Chair Department of Geriatric Medicine John A. Burns School of Medicine, UH Manoa September 5, 2018 10:00 11:00
More informationLower Urinary Tract Symptoms BPH vs OAB FLOW vs VOLUME. Matt T. Rosenberg, MD Family Practice Mid Michigan Health Centers Jackson, Michigan
Lower Urinary Tract Symptoms BPH vs OAB FLOW vs VOLUME Matt T. Rosenberg, MD Family Practice Mid Michigan Health Centers Jackson, Michigan 1 Definition of OAB Syndrome or symptom complex defined as urgency,
More informationAssociation of BPH with OAB: The Plumbing or the Pump?
Association of BPH with OAB: The Plumbing or the Pump? Ryan P. Terlecki, MD FACS Associate Professor of Urology Director, Men s Health Clinic Director, GURS Fellowship in Reconstructive Urology, Prosthetic
More informationOveractive Bladder. When to see a doctor. Normal bladder function
Overactive Bladder Overactive bladder is a problem with bladder-storage function that causes a sudden urge to urinate. The urge may be difficult to stop, and overactive bladder may lead to the involuntary
More informationDisclosures. Geriatric Incontinence and Voiding Dysfunction. Agenda. Agenda. UI: a Geriatric Syndrome. Geriatric Syndromes 9/7/2018.
Disclosures Geriatric Incontinence and Voiding Dysfunction None Shachi Tyagi MD, MS Assistant Professor Division of Geriatric Medicine University of Pittsburgh Medical Center UI: a Geriatric Syndrome Geriatric
More informationPatient Information. Basic Information on Overactive Bladder Symptoms. pubic bone. urethra. scrotum. bladder. vaginal canal
Patient Information English Basic Information on Overactive Bladder Symptoms The underlined terms are listed in the glossary. What is the bladder? pubic bone bladder seminal vesicles prostate rectum The
More informationTreatment of OAB in postmenopause. Držislav Kalafatić Department Obstetrics and Gynecology School of Medicine, University of Zagreb
Treatment of OAB in postmenopause Držislav Kalafatić Department Obstetrics and Gynecology School of Medicine, University of Zagreb Spectrum of overactive bladder Urinary urgency usually accompanied by
More informationTaking Control of your Bladder, or. Don't make me laugh when laughter isn't the best medicine: a discussion on urinary incontinence
Taking Control of your Bladder, or Don't make me laugh when laughter isn't the best medicine: a discussion on urinary incontinence Brett Vassallo, MD, FACOG, FAC Female Pelvic Medicine and Reconstructive
More informationThe Management of Overactive Bladder Syndrome with Antimuscarinic Drugs
The Management of Overactive Bladder Syndrome with Antimuscarinic Drugs Author Version Date Consultation Date of Ratification By JPG Shaista Hussain Joint Formulary Pharmacist V2 16.09.2014 Homerton University
More informationOveractive Bladder Syndrome
Page 1 of 5 Overactive Bladder Syndrome Overactive bladder syndrome is common. Symptoms include an urgent feeling to go to the toilet, going to the toilet frequently, and sometimes leaking urine before
More informationIncontinence: The silent scourge of the young and old. The International Continence Society has. In this article:
Focus on CME at the University of Toronto Incontinence: The silent scourge of the young and old By Sender Herschorn, BSc, MDCM, FRCSC In this article: 1. What is the workup for urinary incontinence? 2.
More informationDr Jonathan Evans Paediatric Nephrologist
How do I manage a patient with intractable daytime wetting: Dr Jonathan Evans Paediatric Nephrologist Of 107 children aged 11-12 with day-wetting 91 (85%) were dry at 15-16 yr Swithinbank et al BJU 1998
More informationOveractive Bladder. Learning Objectives
Learning Objectives Describe neurophysiology of urinary storage and voiding and alterations that occur with pathology Define Overactive Bladder (OAB) and benign prostatic enlargement (BPE) and their impacts
More informationOveractive Bladder (OAB) and Quality of Life
Overactive Bladder (OAB) and Quality of Life Dr. Byron Wong MBBS (Sydney), FRCSEd, FRCSEd (Urol), FCSHK, FHKAM (Surgery) Specialist in Urology Central Urology Clinic Hong Kong Continence Society Annual
More informationGeriatric Urinary Incontinence
Geriatric Urinary Incontinence Neil M. Resnick, MD Thomas Detre Professor of Medicine Chief, Division of Geriatric Medicine University of Pittsburgh/UPMC UI: The Problem Prevalence in elderly 33% Morbidity
More informationURINARY INCONTINENCE
Center for Continence Care and Pelvic Medicine What is urinary incontinence? URINARY INCONTINENCE Urinary incontinence is the uncontrollable loss of urine. The amount of urine leaked can vary from only
More informationIncontinence. Anatomy The human body has two kidneys. The kidneys continuously filter the blood and make urine.
Incontinence Introduction Urinary incontinence occurs when a person cannot control the emptying of his or her urinary bladder. It can happen to anyone, but is very common in older people. Urinary incontinence
More informationBotulinum Toxin Injection for OAB: Indications & Technique
Classification of LUTS Botulinum Toxin Injection for OAB: Indications & Technique Sherif Mourad, MD Professor of Urology, Ain Shams University General Secretary of International Continence President of
More informationOveractive Bladder (OAB) Step Therapy Program Policy Number: Last Review: Origination: Next Review: Policy When Policy Topic is covered:
Overactive Bladder (OAB) Step Therapy Program Policy Number: 5.01.556 Origination: 07/2013 Last Review: 11/2014 Next Review: 11/2015 Policy BCBSKC will provide coverage for brand name Overactive Bladder
More informationLower Urinary Tract Symptoms K Kuruvilla Zachariah Associate Specialist
Lower Urinary Tract Symptoms K Kuruvilla Zachariah Associate Specialist Lower Urinary Tract Symptoms Storage Symptoms Frequency, urgency, incontinence, Nocturia Voiding Symptoms Hesitancy, poor flow, intermittency,
More informationUrinary Incontinence. Lora Keeling and Byron Neale
Urinary Incontinence Lora Keeling and Byron Neale Not life threatening. Introduction But can have a huge impact on quality of life. Two main types of urinary incontinence (UI). Stress UI leakage on effort,
More informationOveractive Bladder (OAB) Step Therapy Program
Overactive Bladder (OAB) Step Therapy Program Policy Number: 5.01.556 Last Review: 11/2018 Origination: 7/2013 Next Review: 11/2019 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will provide
More informationTable 1. International Consultation on Incontinence recommendations for frail older adults
Table 1. International Consultation on Incontinence recommendations for frail older adults Clinicians need to assess and manage co-existing co morbid conditions which are known to have an impact on continence
More informationFaculty. Louis Kuritzky, MD Clinical Assistant Professor Department of Community Health & Family Medicine University of Florida Gainesville, FL
OAB Made Simple for the Primary Care Provider (PCP): Emerging Challenges In Primary Care: 2014! OAB Made Simple for the Primary Care Provider (PCP): How to Identify, When to Treat and When to Refer Faculty
More informationSELF CARE IN URINARY INCONTINENCE
O P I N I O N SelfCare 2011;2(6):160-166 Advancing the study&understanding of self-care JULIAN SPINKS General Practitioner, Medway Primary Care Trust ABSTRACT Urinary incontinence and its associated urinary
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Urinary incontinence in women: the management of urinary incontinence in women 1.1 Short title Urinary incontinence in women
More informationUrinary Incontinence and Overactive Bladder Update NICE Guidelines on UI for women - GP Perspectives
Urinary Incontinence and Overactive Bladder Update NICE Guidelines on UI for women - GP Perspectives Arun Sahai PhD, FRCS (Urol) Consultant Urological Surgeon & Honorary Senior Lecturer Guy s Hospital
More informationDee E. Fenner, M.D. Chair and Furlong Professor of Women s Health Dept. of Obstetrics and Gynecology University of Michigan.
Management of Overactive Bladder Dee E. Fenner, M.D. Chair and Furlong Professor of Women s Health Dept. of Obstetrics and Gynecology University of Michigan deef@umich.edu Disclosures NONE Objectives Review
More informationManaging Female Urinary Incontinence Within Primary Care
Managing Female Urinary Incontinence Within Primary Care Angela Patterson Lead Clinical Nurse Specialist in Bladder and Bowel Dysfunction. South Eastern HSCT Background More than 14 million in the UK affected
More informationPhiladelphia College of Osteopathic Medicine. Victoria J. Kopec Philadelphia College of Osteopathic Medicine,
Philadelphia College of Osteopathic Medicine DigitalCommons@PCOM PCOM Physician Assistant Studies Student Scholarship Student Dissertations, Theses and Papers 2015 Does Treatment With OnabotulinumtoxinA
More informationEvaluation and Treatment of Incontinence
Evaluation and Treatment of Incontinence Classification of Incontinence Failure to empty: Overflow incontinence Failure to store Stress Incontinence Urge Incontinence Physiology of voiding CNS Brain sends
More information21/03/2016. The urogynaecologist approach. Urinary continence management in women: a multidisciplinary approach. Dr Anna Rosamillia
Urinary continence management in women: a multidisciplinary approach The urogynaecologist approach Dr Anna Rosamillia What is normal bladder function? Incontinence is not normal Normal voiding is 7-8 times
More informationUrogynecology in EDS. Joan L. Blomquist, MD Greater Baltimore Medical Center August 2018
Urogynecology in EDS Joan L. Blomquist, MD Greater Baltimore Medical Center August 2018 One in three like me Voiding Issues Frequency/Urgency Urinary Incontinence neurogenic bladder Neurologic supply
More informationUpdates in the nonpharmacological. treatment on overactive bladder
Updates in the nonpharmacological treatment on overactive bladder Overactive Bladder Also known as urgency-frequency syndrome Symptoms Urgency Daytime frequency Nocturia Urge urinary incontinence Sudden
More information25-Feb-16 MANAGEMENT OF URINARY INCONTINENCE IN WOMEN.
Female Urinary Incontinence: GP resources MANAGEMENT OF URINARY INCONTINENCE IN WOMEN Dr Marcus Carey 20 February 2016 www.thewomens.org.au Clinical Practice Guidelines GP management of female urinary
More informationAgePage. Urinary Incontinence
National Institute on Aging AgePage Urinary Incontinence Sarah loves to spend time with her friends talking about grandchildren and visiting with neighbors. But lately she s been having a big problem that
More informationOVERACTIVE BLADDER (OAB)
OVERACTIVE BLADDER (OAB) Ms Taryn Hallam Alana Health Care for Women Women s Health Training Associates OVERACTIVE BLADDER The most misdiagnosed and misunderstood of all the urinary disorders. Problem???
More informationDr. Melissa Kagarise, PA C
Dr. Melissa Kagarise, PA C This program has been supported by an educational grant from Pfizer Pharmaceuticals PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of
More informationDiagnosis and treatment of overactive bladder (nonneurogenic) in adults: AUA/SUFU guideline.
Diagnosis and treatment of overactive bladder (nonneurogenic) in adults: AUA/SUFU guideline. IDENTITY Citation Gormley EA, Lightner DJ, Burgio KL, Chai TC, Clemens JQ, Culkin DJ, Das AK, Foster HE Jr,
More informationAgePage. Urinary Incontinence
National Institute on Aging AgePage Urinary Incontinence Sarah loves to spend time with her friends talking about grandchildren and visiting with neighbors. But lately she s been having a big problem that
More informationRational Pharmacotherapy for LUTS in Older People. Dr William Gibson MBChB MRCP
Rational Pharmacotherapy for LUTS in Older People Dr William Gibson MBChB MRCP Frailty Frailty = state of increased vulnerability resulting from agingassociated decline in reserve and function NOT synonymous
More informationSupplement. Updated Literature Search for Pharmacologic Treatments for Urgency UI
Supplement. Updated Literature Search for Pharmacologic Treatments for Urgency UI Authors: Tatyana A. Shamliyan, MD, MS Senior Director, Evidence-Based Medicine Quality Assurance Elsevier 1600 JFK Blvd,
More informationTraining a Wayward Bladder
D. James Ballard, PT, DPT, GCS The University of Utah, Dept. of Physical Therapy Training a Wayward Bladder Agenda 1. Discuss urinary incontinence 2. Review pelvic floor and lower urinary tract functional
More informationWhen Laughing is No Longer Funny Managing Transient Urinary Incontinence in Hospitalized Elderly Women
When Laughing is No Longer Funny Managing Transient Urinary Incontinence in Hospitalized Elderly Women Grace Umejei, BSN, RN, CWOC. Texas Health Presbyterian Hospital Dallas NICHE Online Connect Webinars
More informationManagement of Urinary Incontinence in Older Women. Dr. Cecilia Cheon Department of Obs. & Gyn. Queen Elizabeth Hospital
Management of Urinary Incontinence in Older Women Dr. Cecilia Cheon Department of Obs. & Gyn. Queen Elizabeth Hospital Epidemiology Causes Investigation Treatment Conclusion Elderly Women High prevalence
More informationIMPROVING URINARY INCONTINENCE
IMPROVING URINARY INCONTINENCE INFORMATION FOR OLDER ADULTS, FAMILIES, AND CAREGIVERS READ THIS PAMPHLET TO LEARN: What Urinary Incontinence is. How to Manage Urinary Incontinence. What Pelvic Floor Exercises
More informationUnknown Risks in Medicare Patients with Overactive Bladder
Unknown Risks in Medicare Patients with Overactive Bladder NMQF Summit April 24, 2017 Pamela Bradt, MD, MPH Executive Medical Director, Urology Medical Affairs, Americas Disclaimer This study was funded
More informationBotulinum Toxin: Applications in Urology
Botulinum Toxin: Applications in Urology Dr. Lee Jonat, PGY-4 Department of Urologic Sciences University of British Columbia Outline Mechanism of Action Technical Considerations Adverse Events Neurogenic
More informationPelvic Floor Therapy for the Neurologic Client Carina Siracusa, PT, DPT, WCS
Pelvic Floor Therapy for the Neurologic Client Carina Siracusa, PT, DPT, WCS OhioHealth, Columbus Ohio Disclosures I have nothing to disclose Objectives Describe the role of a pelvic floor therapist in
More informationCDEC FINAL RECOMMENDATION
CDEC FINAL RECOMMENDATION MIRABEGRON (Myrbetriq Astellas Pharma Canada Inc.) Indication: Overactive Bladder Recommendation: The Canadian Drug Expert Committee (CDEC) recommends that mirabegron be listed
More informationModule 3 Causes Of Urinary Incontinence
Causes Of Urinary Incontinence V4: Last Reviewed September 2017 Learning Outcomes Appreciate the numerous requirements and skills necessary for the person to achieve and maintain urinary continence Discuss
More informationIncontinence; Lets talk about it. Karanvir Virk M.D. Minimally Invasive and Pelvic Reconstructive Surgery
Incontinence; Lets talk about it Karanvir Virk M.D. Minimally Invasive and Pelvic Reconstructive Surgery Select the most appropriate subtitle for this talk A: Bladders gone wild! B: There s no such thing
More informationDrugs for the overactive bladder: are there differences in persistence and compliance?
Editorial Drugs for the overactive bladder: are there differences in persistence and compliance? Karl-Erik Andersson 1,2 1 Institute for Regenerative Medicine, Wake Forest University School of Medicine,
More informationSELECTED POSTER PRESENTATIONS
SELECTED POSTER PRESENTATIONS The following summaries are based on posters presented at the American Urogynecological Society 2004 Scientific Meeting, held July 29-31, 2004, in San Diego, California. CENTRAL
More informationThe International Continence Society
REPORTS Safety and Tolerability of Tolterodine for the Treatment of Overactive Bladder in Adults Richard G. Roberts, MD, JD; Alan D. Garely, MD; and Tamara Bavendam, MD Abstract This article evaluates
More informationIntroduction. EAPEN RS, RADOMSKI SB. Gender differences in overactive bladder. Can J Urol 2016;23(Suppl 1):2-9.
Renu S. Eapen, MD, Sidney B. Radomski, MD Division of Urology, Toronto Western Hospital, University of Toronto, Toronto, Ontario, Canada EAPEN RS, RADOMSKI SB. Gender differences in overactive bladder.
More informationBladder Matters. Peggy P. Francis DNP, RN, MSN, CS, FNP-BC
Bladder Matters Peggy P. Francis DNP, RN, MSN, CS, FNP-BC Disclosures Please be advised that I am on the following speaker bureaus: Astellas/GlaxoSmithKline Ortho Women s Health/Bayer Healthcare Pfizer
More informationUrinary incontinence in women
Urinary incontinence in women Lauren N Wood, 1 Jennifer T Anger 2 1 Cedars-Sinai Medical Center, Department of Surgery, Division of Urology, Los Angeles, CA, USA 2 Urologic Reconstruction, Urodynamics,
More informationUrinary Incontinence. Lee A. Jennings, MD, MSHS. Assistant Professor Reynolds Department of Geriatrics University of Oklahoma Health Sciences Center
Urinary Incontinence Lee A. Jennings, MD, MSHS Assistant Professor Reynolds Department of Geriatrics University of Oklahoma Health Sciences Center Slides adapted from Alison Moore, MD, MPH University of
More informationGeriatric Giants Lecture Series: Urinary incontinence
Geriatric Giants Lecture Series: Urinary incontinence Learning objectives To demonstrate an understanding of : definition of urinary incontinence physiological control of the micturition cycle changes
More information